Depomed reported $13.35M in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aerie Pharmaceuticals AERI:US $ -30.76M 0.92M
Ani Pharmaceuticals ANIP:US $ 8.01M 3.32M
Aurora Cannabis Inc ACB:CN -25958000 65.4M
Daiichi Sankyo 4568:JP Y 53261M 7192M
Depomed DEPO:US $ 13.35M 17.87M
Ironwood Pharmaceuticals IRWD:US $ 65.46M 0.24M
Johnson & Johnson JNJ:US $ 8192M 2043M
Knight Therapeutics Inc GUD:CN C$ 17.02M 7.66M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Omeros OMER:US $ -17936000 5.72M
Pfizer PFE:US $ 10235M 2245M
Teva Pharmaceutical TEVA:IT 1.14B 1000K